Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01874158 · ClinicalTrials.gov registry record
DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women
A clinical trial, sponsored by Tulane University Health Sciences Center.
- Completed
- Registry status
- 99
- Enrollment target
NCT01874158 is a clinical trial that has completed, run by Tulane University Health Sciences Center. The registered enrollment target is 99 participants.
The verdict
NCT01874158 has completed, sponsored by Tulane University Health Sciences Center.
- COMPLETED
- Registry status
- 99 participants
- Enrollment target
Study Summary
The objective of this study is to screen treated Trichomonas vaginalis (TV) positive women weekly using culture and Polymerase Chain Reaction (PCR) to determine how long TV DNA is detectable post treatment and to examine potential confounders to clearance such as bacterial vaginosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01874158
The ClinicalTrials.gov registry entry for NCT01874158 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 99 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University Health Sciences Center, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01874158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01874158 about?
NCT01874158 is a clinical study titled "DNA Clearance of Uncomplicated Trichomonas Vaginalis Infections in HIV Negative Women". The objective of this study is to screen treated Trichomonas vaginalis (TV) positive women weekly using culture and Polymerase Chain Reaction (PCR) to determine how long TV DNA is detectable post treatment and to examine potential confounders to clearance such as bacterial vaginosis.
What is the current status of trial NCT01874158?
This trial is currently completed. The enrollment target is 99 participants. The study started on 2012-11. Estimated completion is 2014-04.
Who is sponsoring clinical trial NCT01874158?
This trial is sponsored by Tulane University Health Sciences Center, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.